Why is Krebs Biochem falling/rising?

As of 19-Sep, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at 77.65, which reflects a decrease of 0.51 or 0.65%. The stock has underperformed its sector by 0.92% today and has been on a consecutive fall for the last two days, resulting in a total decline of 4.14% during this period. Additionally, the stock's performance over various time frames shows a year-to-date decline of 16.05% and a three-year drop of 35.35%, indicating a significant underperformance compared to the Sensex, which has gained 5.74% year-to-date. The stock's delivery volume has also seen a drastic decrease of 78.23% compared to its five-day average, suggesting falling investor participation.
In the broader market context, the stock's short-term return of -0.65% today contrasts with the Sensex's gain of 0.88% over the same period, highlighting its underperformance relative to the benchmark. While the stock is trading above its 20-day moving averages, it remains below its 5-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The lack of available positive or negative factors further complicates the outlook, as there are no specific catalysts identified that could reverse the current downward trajectory.